1. Home
  2. LQDA
  3. LQDA News

Latest Liquidia Corporation (LQDA) News on October 9, 2025

Is IPF the Next Big Market Opportunity for United Therapeutics?
LQDA

Zacks

7 days ago

Is IPF the Next Big Market Opportunity for United Therapeutics?

3 Growth Companies With High Insider Ownership Seeing Up To 63% Revenue Growth
LQDA

Simply Wall St.

8 days ago

3 Growth Companies With High Insider Ownership Seeing Up To 63% Revenue Growth

Jefferies Highlights Yutrepia’s Market Edge in Supporting a Buy on Liquidia (LQDA)
LQDA

Insider Monkey

a month ago

Jefferies Highlights Yutrepia’s Market Edge in Supporting a Buy on Liquidia (LQDA)

Court Victory and Fresh Funding Propel Growth at Liquidia Corporation
LQDA

Insider Monkey

2 months ago

Court Victory and Fresh Funding Propel Growth at Liquidia Corporation

LQDA

MT Newswires

3 months ago

BTIG Cuts Price Target on Liquidia to $40 From $45, Maintains Buy Rating

LQDA

MT Newswires

4 months ago

Liquidia Gets $50 Million From Healthcare Royalty

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™
LQDA

GlobeNewswire

4 months ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Top Growth Companies With Insider Stakes In June 2025
LQDA

Simply Wall St.

4 months ago

Top Growth Companies With Insider Stakes In June 2025

Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia
LQDA

Investor's Business Daily

4 months ago

Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia

LQDA

MT Newswires

4 months ago

Liquidia Set to Make First Commercial Shipment of Yutrepia for Pulmonary Hypertension

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
LQDA

GlobeNewswire

4 months ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference
LQDA

GlobeNewswire

4 months ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

LQDA

MT Newswires

4 months ago

Jefferies Lifts Liquidia Technologies' Price Target to $31 From $27, Buy Rating Kept

FDA Approves Liquidia Corporation (LQDA)’s YUTREPIA Amid Patent Dispute
LQDA

Insider Monkey

4 months ago

FDA Approves Liquidia Corporation (LQDA)’s YUTREPIA Amid Patent Dispute

LQDA

MT Newswires

5 months ago

Liquidia Receives FDA Approval on Yutrepia for Treatment of Pulmonary Hypertension

U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
LQDA

GlobeNewswire

5 months ago

U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

3 Growth Companies With Insider Ownership Up To 19%
LQDA

Simply Wall St.

5 months ago

3 Growth Companies With Insider Ownership Up To 19%

LQDA

MT Newswires

5 months ago

Oppenheimer Downgrades Liquidia to Underperform From Perform, Price Target is $13

LQDA

MT Newswires

5 months ago

Liquidia Faces Patent Litigation Filed by United Therapeutics

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics
LQDA

GlobeNewswire

5 months ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

Liquidia First Quarter 2025 Earnings: Misses Expectations
LQDA

Simply Wall St.

5 months ago

Liquidia First Quarter 2025 Earnings: Misses Expectations

Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ...
LQDA

GuruFocus.com

5 months ago

Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ...

Buckley Capital’s Views on Liquidia Corp. (LQDA)
LQDA

Insider Monkey

5 months ago

Buckley Capital’s Views on Liquidia Corp. (LQDA)

LQDA

MT Newswires

5 months ago

Liquidia Shares Fall After Q1 Net Loss Widens, Revenue Trails Analyst Estimates

Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates
LQDA

Zacks

5 months ago

Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update
LQDA

GlobeNewswire

5 months ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

Earnings To Watch: Liquidia Corp (LQDA) Reports Q1 2025 Result
LQDA

GuruFocus.com

5 months ago

Earnings To Watch: Liquidia Corp (LQDA) Reports Q1 2025 Result

Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference
LQDA

GlobeNewswire

5 months ago

Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference

Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?
LQDA

Zacks

5 months ago

Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
LQDA

GlobeNewswire

5 months ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025
LQDA

GlobeNewswire

5 months ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Urogen Pharma (URGN) Moves 14.1% Higher: Will This Strength Last?
LQDA

Zacks

5 months ago

Urogen Pharma (URGN) Moves 14.1% Higher: Will This Strength Last?

3 Top Growth Companies With Strong Insider Ownership
LQDA

Simply Wall St.

6 months ago

3 Top Growth Companies With Strong Insider Ownership

Great week for Liquidia Corporation (NASDAQ:LQDA) institutional investors after losing 1.5% over the previous year
LQDA

Simply Wall St.

6 months ago

Great week for Liquidia Corporation (NASDAQ:LQDA) institutional investors after losing 1.5% over the previous year

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
LQDA

GlobeNewswire

6 months ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
LQDA

GlobeNewswire

6 months ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

LQDA

MT Newswires

6 months ago

Liquidia Says FDA to Review New Drug Application for Yutrepia

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder
LQDA

GlobeNewswire

6 months ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference
LQDA

GlobeNewswire

6 months ago

Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference

Discover 3 Top Growth Companies With Significant Insider Ownership
LQDA

Simply Wall St.

6 months ago

Discover 3 Top Growth Companies With Significant Insider Ownership

Earnings To Watch: Liquidia Corp (LQDA) Reports Q4 2024 Result
LQDA

GuruFocus.com

7 months ago

Earnings To Watch: Liquidia Corp (LQDA) Reports Q4 2024 Result

Liquidia Full Year 2024 Earnings: Misses Expectations
LQDA

Simply Wall St.

7 months ago

Liquidia Full Year 2024 Earnings: Misses Expectations

LQDA

MT Newswires

7 months ago

Liquidia Files Secondary Common Stock Shelf

LQDA

Thomson Reuters StreetEvents

7 months ago

Q4 2024 Liquidia Corp Earnings Call

LQDA

MT Newswires

7 months ago

Needham Raises Liquidia's Price Target to $25 From $19, Maintains Buy Rating

Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates
LQDA

Zacks

7 months ago

Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates

LQDA

MT Newswires

7 months ago

Liquidia 2024 Loss Widens, Revenue Decreases

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update
LQDA

GlobeNewswire

7 months ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million
LQDA

GlobeNewswire

7 months ago

Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million

One Liquidia Insider Raised Their Stake In The Previous Year
LQDA

Simply Wall St.

7 months ago

One Liquidia Insider Raised Their Stake In The Previous Year

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025
LQDA

GlobeNewswire

7 months ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors
LQDA

GlobeNewswire

7 months ago

Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors

US Growth Stocks With High Insider Ownership Seeing Up To 48% Revenue Growth
LQDA

Simply Wall St.

8 months ago

US Growth Stocks With High Insider Ownership Seeing Up To 48% Revenue Growth

Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last?
LQDA

Zacks

9 months ago

Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last?

3 US Growth Stocks With Strong Insider Ownership
LQDA

Simply Wall St.

9 months ago

3 US Growth Stocks With Strong Insider Ownership

LQDA

MT Newswires

9 months ago

Liquidia Insider Sold Shares Worth $275,299, According to a Recent SEC Filing

Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
LQDA

GlobeNewswire

9 months ago

Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jim Cramer’s Hidden Gem: Why Liquidia Corporation (LQDA) Is the Undervalued Stock You Need to Know
LQDA

Insider Monkey

9 months ago

Jim Cramer’s Hidden Gem: Why Liquidia Corporation (LQDA) Is the Undervalued Stock You Need to Know

LQDA

MT Newswires

10 months ago

Wells Fargo Initiates Coverage on Liquidia With Overweight Rating, $20 Price Target

December 2024 US Growth Stocks With Strong Insider Ownership
LQDA

Simply Wall St.

10 months ago

December 2024 US Growth Stocks With Strong Insider Ownership

Here’s Arquitos Capital Management’s Updates on Liquidia (LQDA)
LQDA

Insider Monkey

10 months ago

Here’s Arquitos Capital Management’s Updates on Liquidia (LQDA)

Does Liquidia Technologies (LQDA) Have the Potential to Rally 132.54% as Wall Street Analysts Expect?
LQDA

Zacks

10 months ago

Does Liquidia Technologies (LQDA) Have the Potential to Rally 132.54% as Wall Street Analysts Expect?

Wall Street Analysts See a 126.13% Upside in Liquidia Technologies (LQDA): Can the Stock Really Move This High?
LQDA

Zacks

10 months ago

Wall Street Analysts See a 126.13% Upside in Liquidia Technologies (LQDA): Can the Stock Really Move This High?

3 US Growth Stocks With At Least 10% Insider Ownership
LQDA

Simply Wall St.

a year ago

3 US Growth Stocks With At Least 10% Insider Ownership

Liquidia Third Quarter 2024 Earnings: Beats Expectations
LQDA

Simply Wall St.

a year ago

Liquidia Third Quarter 2024 Earnings: Beats Expectations

Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ...
LQDA

GuruFocus.com

a year ago

Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ...

Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates
LQDA

Zacks

a year ago

Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update
LQDA

GlobeNewswire

a year ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Liquidia to Present at the Stifel 2024 Healthcare Conference
LQDA

GlobeNewswire

a year ago

Liquidia to Present at the Stifel 2024 Healthcare Conference

Earnings To Watch: Liquidia Corp (LQDA) Reports Q3 2024 Result
LQDA

GuruFocus.com

a year ago

Earnings To Watch: Liquidia Corp (LQDA) Reports Q3 2024 Result

Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue to Soar?
LQDA

Zacks

a year ago

Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue to Soar?

Investors in Liquidia (NASDAQ:LQDA) have seen stellar returns of 186% over the past five years
LQDA

Simply Wall St.

a year ago

Investors in Liquidia (NASDAQ:LQDA) have seen stellar returns of 186% over the past five years

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024
LQDA

GlobeNewswire

a year ago

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024
LQDA

GlobeNewswire

a year ago

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024

Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know
LQDA

Zacks

a year ago

Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know

Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
LQDA

Zacks

a year ago

Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

3 US Growth Stocks With High Insider Ownership And Earnings Growth Up To 61%
LQDA

Simply Wall St.

a year ago

3 US Growth Stocks With High Insider Ownership And Earnings Growth Up To 61%

LQDA

MT Newswires

a year ago

Scotiabank Initiates Liquidia at Sector Outperform With $30 Price Target

Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ...
LQDA

GuruFocus.com

a year ago

Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ...

Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains?
LQDA

Zacks

a year ago

Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains?

LQDA

MT Newswires

a year ago

Liquidia Shares Jump After US Supreme Court Rejects United Therapeutics' Appeal in Patent Dispute

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent
LQDA

GlobeNewswire

a year ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent

LQDA

MT Newswires

a year ago

Liquidia Expands Exclusive Licensing Agreement with Pharmosa Biopharm

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)
LQDA

GlobeNewswire

a year ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting
LQDA

GlobeNewswire

a year ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Travere (TVTX) Soars 5.9%: Is Further Upside Left in the Stock?
LQDA

Zacks

a year ago

Travere (TVTX) Soars 5.9%: Is Further Upside Left in the Stock?

LQDA

MT Newswires

a year ago

Liquidia Says United Therapeutics' Interference Found by US Court to Have Caused Losses of Over $137 Million

With 38% ownership in Liquidia Corporation (NASDAQ:LQDA), institutional investors have a lot riding on the business
LQDA

Simply Wall St.

a year ago

With 38% ownership in Liquidia Corporation (NASDAQ:LQDA), institutional investors have a lot riding on the business

Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million
LQDA

GlobeNewswire

a year ago

Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

LQDA

GuruFocus.com

a year ago

Caligan Partners LP Bolsters Portfolio with Significant Stake in Liquidia Corp

Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock?
LQDA

Zacks

a year ago

Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock?

LQDA

MT Newswires

a year ago

Liquidia to Raise $67.5 Million From Public Offering, Private Placement of Shares

Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement
LQDA

GlobeNewswire

a year ago

Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement

LQDA

MT Newswires

a year ago

Liquidia Seeks Stay on FDA Exclusivity Approval of Rival Version of Hypertension Drug

Liquidia to Present at Upcoming Investor Conferences
LQDA

GlobeNewswire

a year ago

Liquidia to Present at Upcoming Investor Conferences

Jim Cramer Says Liquidia Corporation (LQDA) Has Been Going ‘Down, Down, Down’
LQDA

Insider Monkey

a year ago

Jim Cramer Says Liquidia Corporation (LQDA) Has Been Going ‘Down, Down, Down’

LQDA

MT Newswires

a year ago

Liquidia Files Legal Challenge Against FDA Decision to Grant 3-Year New Clinical Investigation Exclusivity to Tyvaso DPI

Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD
LQDA

GlobeNewswire

a year ago

Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD

Biotech Stock Roundup: CRL for REGN, GILD's Drug Approval, LQDA Down on News
LQDA

Zacks

a year ago

Biotech Stock Roundup: CRL for REGN, GILD's Drug Approval, LQDA Down on News

Liquidia (LQDA) Down on FDA Delaying Full Approval for Yutrepia
LQDA

Zacks

a year ago

Liquidia (LQDA) Down on FDA Delaying Full Approval for Yutrepia

Share on Social Networks: